Russian Academy's of Sciences Immunology Institute and "Petrovaks-pharm" company developed unique drug "Longidaza", which cures urologic and gynecological pathologies, accompanied with connective tissue hyperplasia, and serious skin complications after traumas, skin burns and surgery.

Tissue hyperplasia causes major complications in the form of skin cicatricial deformity after traumas, skin burns, surgery and pathologies of bronchopulmonary, urogenital and digestive tracts. For more than 40 years medical treatment for such cases included hyaluronidase containing enzyme pharmaceuticals, for example, which have several major drawbacks.

Experts consider "Longidaza" to be the drug of 21st century, which effectively inhibits overgrowth of connective tissue, destructs already formed locuses and stops inflammation development - the cause of hyperplasia. In other words, it acts as a cure during all stages of pathology development. This agent is the innovation for curing keloid scars that appear after traumas, skin burns and surgery, eliminating negative consequences of inflammatory processes, prostatitis, pulmonary tuberculosis, as well as promoting antibiotic bioavailability.

Clinical tests showed significant mend of 80% of patients, who used "Longidaza" suppositories.

"Longidaza" drug can be used for treatment of various gynecological pathologies, including tube-peritoneal sterility. Scientists combined "Longidaza" effect with laparoscopic adhesiotomy and helped 70% women to get pregnant.

This unique agent helps to cure scars, burns and other serious injuries. Before the agent was synthesized, medics used to treat scars with hormones, the method, which has some consequences.

"Longidaza" has passed clinical trials - over a thousand people had finished their therapy with this drug. The drug showed to be totally harmless - it doesn't ill-affect patients, is highly effective and causes no allergy and other undesirable reactions, which is very important. "Longidaza" is fine for plastic surgery too.